| Name |
Format |
Description |
Link |
| CCDR: Volume 47-3, March 2021: Influenza and Other Respiratory Viruses |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr.html |
| How COVID-19 vaccines will be regulated for safety and effectiveness |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-3-march-2021/covid-19-vaccine-safety-effectiveness.html |
| Impact of nonpharmaceutical interventions on laboratory detections of influenza A and B in Canada |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-3-march-2021/epidemiologic-seasonal-influenza-covid-19-shutdowns.html |
| Measles surveillance in Canada, 2019 |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-3-march-2021/measles-annual-surveillance-report-2019.html |
| Knowledge brokering on infectious diseases for public health |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-3-march-2021/public-health-knowledge-brokering.html |
| Vaccine against SARS-CoV-2: Challenges and considerations |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-3-march-2021/sars-cov-2-vaccine-challenges-considerations.html |
| Canadian national COVID-19 genomics surveillance priorities for existing and emerging variants of concern |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-3-march-2021/sars-cov-2-variants.html |
| Seasonality of coronaviruses and other respiratory viruses in Canada: Implications for COVID-19 |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-3-march-2021/seasonal-patterns-coronavirus-respiratory-viruses.html |
| Designing tailored interventions to address barriers to vaccination |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-3-march-2021/vaccine-hesitancy.html |
| CCDR: Volume 47-3, March 2021: Influenza and Other Respiratory Viruses |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc.html |
| Vaccine against SARS-CoV-2: Challenges and considerations |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-3-mars-2021/defis-considerations-vaccin-sras-cov-2.html |
| Impact of nonpharmaceutical interventions on laboratory detections of influenza A and B in Canada |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-3-mars-2021/epidemiologiques-grippe-saisonniere-fermetures-covid-19.html |
| Designing tailored interventions to address barriers to vaccination |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-3-mars-2021/hesitation-vaccination.html |
| Seasonality of coronaviruses and other respiratory viruses in Canada: Implications for COVID-19 |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-3-mars-2021/modeles-saisonniers-coronavirus-virus-respiratoires.html |
| Measles surveillance in Canada, 2019 |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-3-mars-2021/rapport-annuel-surveillance-rougeole-2019.html |
| Knowledge brokering on infectious diseases for public health |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-3-mars-2021/sante-publique-courtage-connaissances.html |
| How COVID-19 vaccines will be regulated for safety and effectiveness |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-3-mars-2021/vaccin-covid-19-innocuite-efficacite.html |
| Canadian national COVID-19 genomics surveillance priorities for existing and emerging variants of concern |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-3-mars-2021/variants-sras-cov-2.html |